[Role of radiation therapy in the management of pancreatic cancer].
Fiche publication
Date publication
août 2018
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine
Tous les auteurs :
Huguet F, Rivin Del Campo E, Antoni D, Vendrely V, Hammel P
Lien Pubmed
Résumé
At diagnosis, about 15% of patients with pancreatic cancer present with a resectable tumour, 50% have a metastatic tumour, and 25% a locally advanced tumor (non-metastatic but unresectable due to vascular invasion) or borderline resectable. Despite the technical progress made in the field of radiation therapy and the improvement of the efficacy of chemotherapy, the prognosis of these patients remains very poor. Recently, the role of radiation therapy in the management of pancreatic cancer has been much debated. This review aims to evaluate the role of radiation therapy for these patients.
Mots clés
Adénocarcinome du pancréas, Borderline, Chemoradiotherapy, Chimioradiothérapie, Folfirinox, Gemcitabine, Localement avancé, Locally advanced, Pancreatic adenocarcinoma, Radiation therapy, Radiothérapie
Référence
Cancer Radiother. 2018 Aug 9;: